On January 8, the quadrivalent HPV vaccine for males aged 9-26 was approved in China.
Recently, males in Hangzhou have started the three-dose vaccination process.
Males are vaccinated against female cervical cancer, male anal cancer and other diseases caused by HPV virus.
At present, males and females can be inoculated with HPV vaccines in more than 40 countries all over the world.
,https://en.hangzhou.com.cn/News/content/2025-01/14/content_8841541.html